D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 37,003 595 World Ranking 6346 National Ranking 3467

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

Mark S. Litwin mainly investigates Prostate cancer, Internal medicine, Surgery, Prostatectomy and Quality of life. The various areas that he examines in his Prostate cancer study include Sexual function, Prostate, Radiation therapy and Gynecology. In his study, which falls under the umbrella issue of Internal medicine, Epidemiology of cancer is strongly linked to Oncology.

His study in Surgery is interdisciplinary in nature, drawing from both Kidney cancer, Renal cell carcinoma, Nephrectomy and Cystoscopy. His Prostatectomy research integrates issues from Logistic regression, Brachytherapy, Medicare beneficiary, Intensive care medicine and Prostate-specific antigen. His Quality of life study combines topics from a wide range of disciplines, such as Cross-sectional study, Physical therapy and Gerontology.

His most cited work include:

  • Quality of life and satisfaction with outcome among prostate-cancer survivors. (1747 citations)
  • Quality of life and satisfaction with outcome among prostate-cancer survivors. (1747 citations)
  • Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. (1098 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Prostatectomy and Gynecology. His research integrates issues of Quality of life, Quality of life, Surgery and Prostate in his study of Prostate cancer. In his research on the topic of Quality of life, Prostatitis and Chronic prostatitis/chronic pelvic pain syndrome is strongly related with Physical therapy.

His Oncology research incorporates themes from Androgen deprivation therapy and Epidemiology of cancer. His Prostatectomy research is multidisciplinary, incorporating elements of Radiation therapy, Brachytherapy, General surgery and Urology. His Gynecology study incorporates themes from Health care quality and Family medicine.

He most often published in these fields:

  • Prostate cancer (50.84%)
  • Internal medicine (40.60%)
  • Oncology (20.13%)

What were the highlights of his more recent work (between 2014-2021)?

  • Prostate cancer (50.84%)
  • Internal medicine (40.60%)
  • Comorbidity (11.74%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Prostate cancer, Internal medicine, Comorbidity, Oncology and Cancer. Mark S. Litwin has researched Prostate cancer in several fields, including Gynecology, Quality of life, Cohort and Family medicine. His study in the field of Bladder cancer, Prospective cohort study and Survival analysis is also linked to topics like Variation.

His biological study spans a wide range of topics, including Survival rate, Surgery, Retrospective cohort study, Gerontology and Nephrectomy. His research in Surgery intersects with topics in Cystectomy, Prostatectomy, Disease and Patient experience. His Cancer research incorporates elements of Odds ratio, Psychiatry, Epidemiology and Hazard ratio.

Between 2014 and 2021, his most popular works were:

  • The Diagnosis and Treatment of Prostate Cancer: A Review. (339 citations)
  • Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. (123 citations)
  • Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. (105 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

His main research concerns Internal medicine, Prostate cancer, Comorbidity, Cancer and Epidemiology. Mark S. Litwin has included themes like Perioperative and Oncology in his Internal medicine study. Mark S. Litwin interconnects Prospective cohort study, Gynecology, Quality of life and Cohort in the investigation of issues within Prostate cancer.

His Quality of life study integrates concerns from other disciplines, such as Urinary system and Brachytherapy. His studies deal with areas such as Stage, Surgery, Kidney cancer and Nephrectomy as well as Epidemiology. As a part of the same scientific family, Mark S. Litwin mostly works in the field of Surgery, focusing on Cystectomy and, on occasion, Disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

How to Measure Survey Reliability and Validity

Mark S. Litwin.
(1995)

3126 Citations

Quality of life and satisfaction with outcome among prostate-cancer survivors.

Martin G. Sanda;Rodney L. Dunn;Jeff Michalski;Howard M. Sandler.
The New England Journal of Medicine (2008)

2404 Citations

The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure

Mark S. Litwin;Mary McNAUGHTON-COLLINS;Floyd J. Fowler;J. Curtis Nickel.
The Journal of Urology (1999)

1620 Citations

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

John T Wei;Rodney L Dunn;Rodney L Dunn;Mark S Litwin;Howard M Sandler.
Urology (2000)

1451 Citations

Quality-of-life Outcomes in Men Treated for Localized Prostate Cancer

Mark S. Litwin;Ron D. Hays;Arlene Fink;Patricia A. Ganz.
JAMA (1995)

1251 Citations

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

Mark S. Litwin;Ron D. Hays;Arlene Fink;Patricia A. Ganz.
Medical Care (1998)

910 Citations

The Diagnosis and Treatment of Prostate Cancer: A Review.

Mark S. Litwin;Hung-Jui Tan.
JAMA (2017)

843 Citations

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.

Christopher S. Saigal;John L. Gore;Tracey L. Krupski;Janet Hanley.
Cancer (2007)

574 Citations

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.

Matthew R. Cooperberg;David J. Pasta;Eric P. Elkin;Mark S. Litwin.
The Journal of Urology (2005)

552 Citations

Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate Cancer

John T. Wei;Rodney L. Dunn;Howard M. Sandler;P. William McLaughlin.
Journal of Clinical Oncology (2002)

524 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark S. Litwin

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 238

David F. Penson

David F. Penson

Vanderbilt University Medical Center

Publications: 163

Matthew R. Cooperberg

Matthew R. Cooperberg

University of California, San Francisco

Publications: 162

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 116

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 115

Quoc-Dien Trinh

Quoc-Dien Trinh

Brigham and Women's Hospital

Publications: 113

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 109

Anthony V. D'Amico

Anthony V. D'Amico

Brigham and Women's Hospital

Publications: 89

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 86

J. Curtis Nickel

J. Curtis Nickel

Queen's University

Publications: 82

John T. Wei

John T. Wei

University of Michigan–Ann Arbor

Publications: 81

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 75

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 72

Peter T. Scardino

Peter T. Scardino

Memorial Sloan Kettering Cancer Center

Publications: 69

Paul L. Nguyen

Paul L. Nguyen

Harvard Medical School

Publications: 68

Michael W. Kattan

Michael W. Kattan

Cleveland Clinic

Publications: 68

Trending Scientists

Suhang Wang

Suhang Wang

Pennsylvania State University

Yanwei Fu

Yanwei Fu

Fudan University

Robert A. Stevenson

Robert A. Stevenson

University of Notre Dame

Eleanor S. Lee

Eleanor S. Lee

Lawrence Berkeley National Laboratory

J. V. Yakhmi

J. V. Yakhmi

Bhabha Atomic Research Center

Barry P. Sleckman

Barry P. Sleckman

University of Alabama at Birmingham

Bill Freedman

Bill Freedman

Dalhousie University

Matthias Dobbertin

Matthias Dobbertin

Swiss Federal Institute for Forest, Snow and Landscape Research

Darren J. Kriticos

Darren J. Kriticos

Commonwealth Scientific and Industrial Research Organisation

Thomas Leitner

Thomas Leitner

Los Alamos National Laboratory

Herren Wu

Herren Wu

AstraZeneca (United Kingdom)

Karel Schulmann

Karel Schulmann

University of Strasbourg

Gary R. Lee

Gary R. Lee

Bowling Green State University

Björn Ekblom

Björn Ekblom

Karolinska Institute

Something went wrong. Please try again later.